Skip to content

Clinical trials

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20041
20052
20092
20111
20151
20172
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Fred Hutchinson Cancer Center3
Goethe University3
Princess Maxima Center for Pediatric Oncology3
Boston Medical Center1
Bristol-Myers Squibb1
Cellestia Biotech AG1
Children's Oncology Group1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma23
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Burkitt Lymphoma11
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Follicular10
Lymphoma, Large B-Cell, Diffuse10
Lymphoma, Mantle-Cell10
Lymphoma, Non-Hodgkin10
Recurrence10
Immunoblastic Lymphadenopathy9

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.